ENTITY
Beijing Tiantan Biological Products

Beijing Tiantan Biological Products (600161 CH)

47
Analysis
Health CareChina
Beijing Tiantan Biological Products Corporation Limited researches, develops, and commercializes biological products. The Company provides treatment for hepatitis and offers a line of vaccine products including hepatitis vaccines and rubella vaccines.
more
03 Jun 2024 16:15

Quiddity SSE50/180 Jun 24 Rebalance: US$1.8bn One-Way Flow; LONGs up 8.6% Vs SHORTs in a Month

On average, the LONGs are up 5.6% and the SHORTs are down 3.0% since the pair trades were suggested (on 6th May 2024). Some of these have to be...

Share

Quiddity CSI 300/​​500 Jun 24 Rebalance: 92% Hit Rate; US$3.7bn One-Way Flows

The Inclusion/Exclusion events can be expected to take place at the close of trading on Friday 14th June 2024. We expect certain inflow names to...

Share
11 Mar 2024 18:39

Quiddity Leaderboard CSI 300/​​500 Jun 24: Exp. One-Way Flow Tops US$3bn Due to Passive AUM Surge

Significant amounts of new passive money has flowed into the CSI 300 and CSI 500 index resulting in a sharp increase in our one-way flow...

Share
28 Jan 2024 05:30

Index Rebalance & ETF Flow Recap: CSI300, CSI500, SSE50, ChiNext, KOSPI200, Renesas, IDX30/LQ45

This recap highlights Insights covering Asian index rebalances (announcements/ forecasts/ IPO Fast Entry/ M&A driven changes). We also highlight...

Logo
524 Views
Share
25 Jan 2024 08:55

Haier Group to Buy $1.8B Stake in Shanghai RAAS from Grifols – A New Chapter Begins

We analyzed the key points/logic behind Haier's decision to acquire Shanghai RAAS from Grifols. Despite potential risks, it is still a wise move...

Logo
492 Views
Share
x